Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Everest Medicines Ltd. ( (HK:1952) ).
Everest Medicines Limited, listed on the Hong Kong Stock Exchange, experienced unusual market price and trading volume movements. The company attributes this to CBC Group, the controlling shareholder, selling 17.1 million shares to international investment institutions in a block trade. Despite this transaction, CBC Group maintains more than a 34% stake, indicating its ongoing commitment. The company’s board assured stakeholders of no material change in its operations or financial standing.
More about Everest Medicines Ltd.
YTD Price Performance: 3.82%
Average Trading Volume: 5,534,870
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$17.2B
For an in-depth examination of 1952 stock, go to TipRanks’ Stock Analysis page.